Northwest & Ethical Investments L.P. Trims Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Northwest & Ethical Investments L.P. reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 17.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,760 shares of the company’s stock after selling 2,679 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Henry Schein were worth $930,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in HSIC. Cromwell Holdings LLC boosted its position in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the period. Summit Securities Group LLC purchased a new position in shares of Henry Schein during the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA bought a new stake in Henry Schein during the second quarter valued at about $37,000. Blue Trust Inc. lifted its position in shares of Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HSIC has been the topic of several recent analyst reports. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Evercore ISI upped their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Barrington Research reiterated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Stock Down 0.8 %

Shares of NASDAQ HSIC opened at $77.05 on Friday. The stock has a market capitalization of $9.61 billion, a price-to-earnings ratio of 31.71, a P/E/G ratio of 2.23 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm’s 50-day moving average price is $71.36 and its 200-day moving average price is $69.89.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.32 earnings per share. On average, equities research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.